Valuation: SSY Group Limited

Market Cap 6.88B 878M 763M 710M 652M 1.23B 83.77B 1.25B 8.37B 3.28B 41.71B 3.3B 3.22B 140B P/E 2026 *
12.2x
P/E 2027 * 9.92x
Enterprise Value 6.88B 878M 763M 710M 652M 1.23B 83.77B 1.25B 8.37B 3.28B 41.71B 3.3B 3.22B 140B EV / Sales 2026 *
1.41x
EV / Sales 2027 * 1.26x
Free-Float
33.48%
Yield 2026 *
4.2%
Yield 2027 * 4.62%
1 day-2.46%
1 week-0.83%
Current month+12.26%
1 month+12.26%
3 months+3.48%
6 months-19.59%
Current year-15.90%
1 week 2.37
Extreme 2.37
2.47
1 month 2.14
Extreme 2.14
2.58
Current year 2.01
Extreme 2.01
3.15
1 year 2.01
Extreme 2.01
3.4
3 years 2.01
Extreme 2.01
5.2
5 years 2.01
Extreme 2.01
5.84
10 years 2.01
Extreme 2.01
9.46
Manager TitleAgeSince
Chief Executive Officer 69 23/03/2010
Director of Finance/CFO 45 01/04/2015
Corporate Officer/Principal 42 28/08/2024
Director TitleAgeSince
Chairman 69 04/06/2014
Director/Board Member 61 26/07/2007
Director/Board Member 57 16/10/2005
Date Insider Type Main position Quantity % Market Cap.
09/01/26 Other

Chief Executive Officer

456,000 0.0155%
08/01/26 Other

Chief Executive Officer

1,486,000 0.0504%
07/01/26 Other

Chief Executive Officer

1,128,000 0.0382%
Change 5-day change 1-year change 3-year change Capi.($)
-2.46%-0.83%-26.09%-45.16% 900M
-0.92%-4.44%+54.44%+151.45% 1,030B
+0.77%-2.14%+56.46%+53.86% 617B
-2.34%-3.10%+32.95%+68.01% 455B
+0.06%-0.42%+37.53%+30.67% 350B
-0.14%-0.24%+34.41%+39.01% 299B
-0.69%-0.30%+11.55%+12.93% 265B
-7.37%-4.40%-2.54%-43.87% 225B
-0.52%+2.30%+30.36%+64.30% 209B
-0.71%+0.71%+15.97%+71.03% 163B
Average -1.37%+4.47%+24.51%+40.22% 361.36B
Weighted average by Cap. -0.95%+4.87%+38.94%+72.24%

Financials

2026 *2027 *
Net sales 4.88B 622M 541M 503M 462M 873M 59.38B 886M 5.93B 2.33B 29.56B 2.34B 2.28B 99.12B 5.47B 698M 607M 565M 518M 979M 66.63B 994M 6.66B 2.61B 33.17B 2.62B 2.56B 111B
Net income 587M 74.87M 65.08M 60.58M 55.62M 105M 7.15B 107M 714M 280M 3.56B 281M 275M 11.93B 702M 89.47M 77.77M 72.39M 66.46M 126M 8.54B 127M 853M 335M 4.25B 336M 329M 14.26B
Net Debt - -
Logo SSY Group Limited
SSY Group Ltd, formerly known as Lijun International Pharmaceutical Holding Co Ltd, is an investment holding company principally engaged in the research, development, manufacture and sale of pharmaceutical products. The Company’s main products include finished medicines of mainly intravenous infusion solution to hospitals and distributors, bulk pharmaceuticals and medical materials. The Company’s products mainly include non-PVC (Polyvinyl chloride) soft bag infusion solution, PP (Polypropylene) plastic bottle infusion solution and Glass bottle infusion solution. The Company’s products also include Hydrochloride Betahistine, Hydrochloride Ambroxol and Doxofylline as well as bulk pharmaceuticals including caffeine, theophylline, aminophylline, metronidazole and nifedipine.
Employees
5,472
Date Price Change Volume
31/07/26 HK$2.380 -2.46% 2,112,500
30/07/26 HK$2.440 -0.81% 3,246,000
29/07/26 HK$2.460 +1.65% 1,894,000
28/07/26 HK$2.420 +1.26% 1,368,000
27/07/26 HK$2.390 -0.42% 1,844,066
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2.380HKD
Average target price
3.640HKD
Spread / Average Target
+52.94%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 2005 Stock